VNDA vs. ALT
VNDA (Vanda Pharmaceuticals Inc.) and ALT (Altimmune, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, VNDA returned -8.15%/yr vs -29.17%/yr for ALT. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
VNDA vs. ALT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VNDA achieves a -42.18% return, which is significantly lower than ALT's -21.33% return. Over the past 10 years, VNDA has outperformed ALT with an annualized return of -8.15%, while ALT has yielded a comparatively lower -29.17% annualized return.
VNDA
- 1D
- -1.54%
- 1M
- -17.87%
- 6M
- -32.36%
- YTD
- -42.18%
- 1Y
- 21.72%
- 3Y*
- -3.30%
- 5Y*
- -20.75%
- 10Y*
- -8.15%
- ALL TIME*
- -3.04%
ALT
- 1D
- -4.70%
- 1M
- -10.13%
- 6M
- -49.29%
- YTD
- -21.33%
- 1Y
- -21.33%
- 3Y*
- -3.60%
- 5Y*
- -20.72%
- 10Y*
- -29.17%
- ALL TIME*
- -19.35%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $14.41M | $12.19M | $11.44M | |
| $4.19M | $4.74M | $5.95M |
VNDA vs. ALT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VNDA Vanda Pharmaceuticals Inc. | -42.18% | 84.13% | 13.51% | -42.90% | -52.90% | 19.41% | -19.93% | -37.20% | 71.91% | -4.70% |
ALT Altimmune, Inc. | -21.33% | -49.93% | -35.91% | -31.61% | 79.59% | -18.79% | 496.83% | -8.25% | -96.55% | -47.79% |
Correlation
The correlation between VNDA and ALT is 0.43, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.43 |
Correlation (3Y) Balances recent behavior with more history. | 0.36 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.34 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.24 |
Correlation (All Time) Calculated using the full available price history since Apr 12, 2006 | 0.17 |
Over the past year, VNDA and ALT have become more correlated (0.43) than their long-term average of 0.17, meaning their price movements have been converging.
Fundamentals
VNDA:
$306.69M
ALT:
$250.65M
VNDA:
-$4.05
ALT:
-$0.87
VNDA:
1.39
ALT:
8.27K
VNDA:
1.08
ALT:
1.24
VNDA:
$217.78M
ALT:
$36.00K
VNDA:
$154.79M
ALT:
-$14.92M
VNDA:
-$146.81M
ALT:
-$93.48M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VNDA vs. ALT — Risk / Return Rank
VNDA
ALT
VNDA vs. ALT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanda Pharmaceuticals Inc. (VNDA) and Altimmune, Inc. (ALT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VNDA | ALT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.58 | ||
| Sortino ratioReturn per unit of downside risk | +1.07 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 0.99 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.42 | -0.40 | +0.82 |
| Martin ratioReturn relative to average drawdown | 0.88 | -0.67 | +1.55 |
Loading charts...
Drawdowns
VNDA vs. ALT - Drawdown Comparison
The maximum VNDA drawdown since its inception was -98.42%, roughly equal to the maximum ALT drawdown of -99.63%. Use the drawdown chart below to compare losses from any high point for VNDA and ALT.
Loading charts...
Drawdown Indicators
| VNDA | ALT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.42% | -99.63% | +1.21% |
Max Drawdown (1Y)Largest decline over 1 year | -47.18% | -58.09% | +10.91% |
Max Drawdown (3Y)Largest decline over 3 years | -47.18% | -81.25% | +34.07% |
Max Drawdown (5Y)Largest decline over 5 years | -84.01% | -90.45% | +6.44% |
Max Drawdown (10Y)Largest decline over 10 years | -89.26% | -99.63% | +10.37% |
Current DrawdownCurrent decline from peak | -83.90% | -99.31% | +15.41% |
Average DrawdownAverage peak-to-trough decline | -65.20% | -79.02% | +13.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.40% | 34.45% | -12.05% |
Volatility
VNDA vs. ALT - Volatility Comparison
Vanda Pharmaceuticals Inc. (VNDA) and Altimmune, Inc. (ALT) have volatilities of 12.17% and 12.15%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VNDA | ALT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.17% | 12.15% | +0.02% |
Volatility (6M)Calculated over the trailing 6-month period | 57.66% | 45.11% | +12.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.78% | 68.95% | +12.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.32% | 92.48% | -32.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 55.71% | 149.74% | -94.03% |
Dividends
VNDA vs. ALT - Dividend Comparison
Neither VNDA nor ALT has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ALT Altimmune, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,462.31% |
VNDA Vanda Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
VNDA vs. ALT - Financials Comparison
This section allows you to compare key financial metrics between Vanda Pharmaceuticals Inc. and Altimmune, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VNDA and ALT have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VNDA has higher volatility (12.17%) compared to ALT (12.15%). In terms of maximum drawdown, VNDA dropped -98.42% vs ALT's -99.63%.
VNDA currently has the higher Sharpe Ratio (0.24 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VNDA and ALT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer